Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of CHF6366 in healthy volunteers and in asthma and COPD patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CHF6366

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma, Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: COMPLETED